Neurologic Manifestation in Children with Coronavirus Disease 2019 at Prof. Dr. I.G.N.G Ngoerah Tertiary Hospital

Authors

  • Michelle Husin Department of Child Health, Medical Faculty, Udayana University, Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar, Bali, Indonesia https://orcid.org/0000-0001-9407-5932
  • Dewi Sutriani Mahalini Department of Child Health, Medical Faculty, Udayana University, Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar, Bali, Indonesia https://orcid.org/0000-0002-6492-3475
  • I Gusti Ngurah Made Suwarba Department of Child Health, Medical Faculty, Udayana University, Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Ni Putu Siadi Purniti Department of Child Health, Medical Faculty, Udayana University, Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Ida Bagus Subanada Department of Child Health, Medical Faculty, Udayana University, Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2023.11619

Keywords:

neurologic manifestation, COVID-19, children

Abstract

AIM: The objective of the study is to describe neurologic manifestation in children with coronavirus disease-2019 (COVID-19) at Prof. Dr. I.G.N.G Ngoerah Hospital.

METHODS: This was a retrospective descriptive study using the medical record with a total sampling of children with confirmed COVID-19 that  manifests neurologic symptoms. Exclusion criteria were pre-existing neurologic comorbidities and incomplete medical records.

RESULTS: From March 2020 to December 2021, from 308 children with confirmed cases of COVID-19, 106 had neurologic symptoms, 17 were  excluded (16 pre-existing comorbidities, and 1 incomplete medical record), and total samples were 89 (28.8%) from inpatient and outpatient. Most children were male (57.3%) with a median age of 13 years. Most symptoms found were anosmia (73%), followed by a decrease in consciousness (19.1%) and seizure (10.1%). Children with anosmia median age were 14 years. There were 84 (94.3%) children with specific neurological symptoms  (encephalopathy, seizures, and anosmia) and 5 (5.7%) with non-specific neurological symptoms (headache).

CONCLUSION: There were 28.8% confirmed cases of COVID-19 with a neurologic manifestation, and most symptoms found were anosmia (73%).

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Indonesia: Kementerian Kesehatan Republik Indonesia; 2020.

Perhimpunan Dokter Paru Indonesia, Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia, Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia, Ikatan Dokter Anak Indonesia. Pedoman Tatalaksana COVID-19 Edisi 3; 2020.

Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: Is there a link? Epilepsia 2020;61:1840-53. DOI: https://doi.org/10.1111/epi.16656

Stafstrom CE, Jantzie LJ. COVID-19: Neurological considerations in neonates and children. Children (Basel). 2020;7(9):133. https://doi.org/10.3390/children7090133 PMid:32927628 DOI: https://doi.org/10.3390/children7090133

Ray ST, Abdel-Mannan O, Sa M, Fuller C, Wood GK, Psyden K, et al. Neurological manifestations of SARS-CoV-2 infection in hospitalized children and adolescents in the UK: A perspective national cohort study. Lancet Child Adolesc Health 2021;5(9):631-41. https://doi.org/10.1016/S2352-4642(21)00193-0 PMid:34273304 DOI: https://doi.org/10.1016/S2352-4642(21)00193-0

Gurlevik SL, Gunbey C, Ozsurekci Y, Oygar PD, Kesici S, Gocmen R, et al. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Eur J Paediatr Nerurol. 2022;37:139-54. https://doi.org/10.1016/j.ejpn.2022.02.003 PMid:35287009 DOI: https://doi.org/10.1016/j.ejpn.2022.02.003

Aljomah L, Almedlej S, Baarmah D, Altwaijri W, Alrumayyan A, Alrifai MT. Pediatrics COVID-19 and neurological manifestations: Single tertiary centre experience. eNeurologicalSci. 2021;24:100355. https://doi.org/10.1016/j.ensci.2021.100355 PMid:34307923 DOI: https://doi.org/10.1016/j.ensci.2021.100355

Parisi GF, Brindisi G, Indolfi C, Diaferio L, Marchese G, Ghiglioni DG, et al. Upper airway involvement in pediatric COVID-19. Pediatr Allergy Immunol. 2020;31(Suppl 26):85-8. https://doi.org/10.1111/pai.13356 PMid:33236430 DOI: https://doi.org/10.1111/pai.13356

Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Clinical review: Neurological complications of SARS-CoV-2 infection in children: A systematic review and meta-analysis. J Trop Pediatr. 2020;67(3):fmaa070. https://doi.org/10.1093/tropej/fmaa070 PMid:32910826 DOI: https://doi.org/10.1093/tropej/fmaa070

Lin JE, Asfour A, Sewell TB, Hooe B, Pryce P, Earley C, et al. Neurological issues in children with COVID-19. Neurosci Lett. 2020;743:135567. https://doi.org/10.1016/j.neulet.2020.135567.2020 PMid:33352286 DOI: https://doi.org/10.1016/j.neulet.2020.135567

Fink EL, Robertson CL, Wainwright MS, Roa JD, Lovett ME, Stulce C. Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33-44. https://doi.org/10.1016/j.pediatrneurol.2021.12.010 PMid:35066369 DOI: https://doi.org/10.1016/j.pediatrneurol.2021.12.010

Kumar L, Kahlon N, Jain A, Kaur J, Singh M, Pandey AK. Loss of smell and taste in COVID-19 infection in adolescents. Int J Pediatr Otorhinolaryngol 2021;142:110626. https://doi.org/10.1016/j.ijporl.2021.110626 PMid:33477014 DOI: https://doi.org/10.1016/j.ijporl.2021.110626

Schober ME, Robertson CL, Wainwright MS, Roa JD, Fink EL.

COVID-19 and the pediatric nervous system: Global collaboration to meet a global need. Neuricrit Care. 2021;35(2):283-90. https://doi.org/10.1007/s12028-021-01269-2 PMid:34184177 DOI: https://doi.org/10.1007/s12028-021-01269-2

Kim YK, Walser SA, Asghar SJ, Jain R, Mainali G, Kumar A. A comprehensive review of neurologic manifestations of COVID-19 and management of pre-existing neurologic disorders in children. J Child Neurol. 2020;36(4):324-30. https://doi.org/10.1177/0883073820968995 PMid:33112694 DOI: https://doi.org/10.1177/0883073820968995

Govil-Dalela T, Sivaswamy L. Neurological effects of COVID-19 in children. Pediatr Clin North Am. 2021;68(5):1081-91. https://doi.org/10.1016/j.pcl.2021.05.010 PMid:34538300 DOI: https://doi.org/10.1016/j.pcl.2021.05.010

Downloads

Published

2023-05-28

How to Cite

1.
Husin M, Mahalini DS, Suwarba IGNM, Purniti NPS, Subanada IB. Neurologic Manifestation in Children with Coronavirus Disease 2019 at Prof. Dr. I.G.N.G Ngoerah Tertiary Hospital. Open Access Maced J Med Sci [Internet]. 2023 May 28 [cited 2024 Nov. 21];11(B):581-5. Available from: https://oamjms.eu/index.php/mjms/article/view/11619